You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《異動股》麗珠醫藥AH股漲逾7%及5.5%齊創紀錄高
阿思達克 07-13 11:38
麗珠醫藥(01513.HK)(000513.SZ)AH股今天齊創紀錄高,H股高見41.7元,現造41.5元,續升5.6%,成交增至75萬股,涉資3,080萬元;其A股高見52.1元人民幣,半日收52.01元,漲7.1%,成交達1,333萬股。

麗珠本月初表示,截至6月30日止,公司通過集中競價交易方式累計回購594.61萬股A股,每股作價介乎38.95-44.88元人民幣,涉及金額2.43億人民幣。公司亦在月初指與德國藥品研發商LTS Lohmann Therapie-Systeme AG簽署授權合作協議,LTS將授予公司阿塞那平透皮貼劑(用於治療精神分裂症)某些知識產權下獨家,包含特許權使用費及可轉授權許可權,而公司需向LTS支付其在開發期間產生所有人工成本,有關費用上限為320萬歐元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account